(TOP (S (S (NP (organization (NNP Rorer) (NNP Group) (NNP Inc.))) (VP (MD will) (VP (VB report) (SBAR (IN that) (S (NP (JJ third-quarter) (NN profit)) (VP (VBD rose) (NP (percentage (QP (JJR more) (IN than) (CD 15)) (NN %))) (PP (IN from) (ADVP (date (NP (DT a) (NN year)) (RBR earlier)))) (, ,) (SBAR (IN though) (S (NP (DT the) (NN gain)) (VP (AUX is) (ADJP (RB wholly) (JJ due) (PP (TO to) (NP (NN asset) (NNS sales))))))))))))) (, ,) (NP (NP (person (NNP Robert) (NNP Cawthorn))) (, ,) (NP (NP (NN chairman)) (, ,) (NP (NN president)) (CC and) (NP (JJ chief) (NN executive) (NN officer))) (, ,)) (VP (VBD said)) (. .)) )
(TOP (S (NP (PRP$ His) (NN projection)) (VP (VBZ indicates) (NP (NP (NN profit)) (PP (IN in) (NP (DT the) (JJS latest) (NN quarter))) (PP (IN of) (NP (NP (NP (QP (JJR more) (IN than) (money ($ $) (CD 17.4) (CD million)))) (, ,) (CC or) (NP (NP (money (CD 55) (NNS cents))) (NP (DT a) (NN share))) (, ,)) (PP (VBN compared) (PP (IN with) (NP (NP (QP (money ($ $) (CD 15.2) (CD million)))) (, ,) (CC or) (NP (NP (money (CD 48) (NNS cents))) (NP (DT a) (NN share))) (, ,) (ADVP (date (NP (DT a) (NN year)) (RB ago)))))))))) (. .)) )
(TOP (S (NP (NNP Mr.) (NNP Cawthorn)) (VP (VBD said) (PP (IN in) (NP (DT an) (NN interview))) (SBAR (IN that) (S (NP (NNS sales)) (VP (MD will) (VP (VB show) (NP (NP (DT an) (NN increase)) (PP (IN from) (ADVP (date (NP (DT a) (NN year)) (RB ago)))) (PP (IN of) (`` `) (`` `) (NP (percentage (QP (RB somewhat) (JJR less) (IN than) (CD 10)) (NN %)))))))))) (. .)) )
(TOP (S ('' ') ('' ') (PP (IN Through) (NP (NP (DT the) (JJ first) (CD six) (NNS months)) (PP (IN of) (NP (date (CD 1989)))))) (, ,) (NP (NNS sales)) (VP (AUX had) (VP (VBN grown) (NP (percentage (QP (RB about) (CD 12)) (NN %))) (PP (IN from) (NP (DT the) (JJ year-earlier) (NN period))))) (. .)) )
(TOP (S (NP (NP (NN Growth)) (PP (IN of) (NP (percentage (CD 10) (NN %))))) (VP (MD would) (VP (VB make) (S (NP (NP (NNS sales)) (PP (IN for) (NP (DT the) (JJS latest) (NN quarter)))) (NP (NP (QP (money ($ $) (CD 269) (CD million)))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (QP (money ($ $) (CD 244.6) (CD million)))) (ADVP (date (NP (DT a) (NN year)) (RB ago)))))))))) (. .)) )
(TOP (S (NP (NNP Mr.) (NNP Cawthorn)) (VP (VBD said) (SBAR (S (NP (NP (DT the) (NN profit) (NN growth)) (PP (IN in) (NP (DT the) (JJS latest) (NN quarter)))) (VP (AUX was) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN sale)) (PP (IN of) (NP (CD two) (NNP Rorer) (NNS drugs)))))))))) (. .)) )
(TOP (S (NP (NP (NNP Asilone)) (, ,) (NP (DT an) (NN antacid)) (, ,)) (VP (AUX was) (VP (VBN sold) (PP (TO to) (NP (NP (organization (NNP Boots) (NNP PLC))) (, ,) (NP (location (NNP London))))))) (. .)) )
(TOP (S (NP (NP (NNP Thrombinar)) (, ,) (NP (NP (DT a) (NN drug)) (VP (VBN used) (S (VP (TO to) (VP (VB stanch) (NP (NN bleeding))))))) (, ,)) (VP (AUX was) (VP (VBN sold) (PP (TO to) (NP (NP (organization (NNP Jones) (NNP Medical) (NNPS Industries) (NNP Inc.))) (, ,) (NP (NNP St.) (NNP Louis)))))) (. .)) )
(TOP (S (NP (PRP He)) (VP (VBD said) (SBAR (S (NP (NNP Rorer)) (VP (VP (VBD sold) (NP (DT the) (NNS drugs)) (PP (IN for) (`` `) (NP (`` `) (JJ nice) (NNS prices) ('' ')) ('' '))) (CC and) (VP (MD will) (VP (VB record) (NP (NP (DT a) (VBN combined) (, ,) (JJ pretax) (NN gain)) (PP (IN on) (NP (NP (DT the) (NNS sales)) (PP (IN of) (NP (QP (money ($ $) (CD 20) (CD million)))))))))))))) (. .)) )
(TOP (S (S (SBAR (IN As) (S (NP (NP (DT the) (NN gain)) (PP (IN from) (NP (DT the) (NNS sales)))) (VP (VBZ indicates)))) (, ,) (NP (NN operating) (NN profit)) (VP (AUX was) (PP (`` `) (ADVP (`` `) (RB significantly) ('' ')) ('' ') (IN below) (NP (DT the) (JJ year-earlier) (NN level))))) (, ,) (NP (NNP Mr.) (NNP Cawthorn)) (VP (VBD said)) (. .)) )
(TOP (S (NP (NNP Rorer)) (PP (IN in) (NP (NNP July))) (VP (AUX had) (VP (VBN projected) (NP (NP (JJR lower) (JJ third-quarter) (NN operating) (NN profit)) (CC but) (NP (NP (JJR higher) (NN profit)) (PP (IN for) (NP (NP (DT all)) (PP (IN of) (NP (date (CD 1989)))))))))) (. .)) )
(TOP (S (NP (PRP He)) (VP (VBD said) (SBAR (S (NP (DT the) (NN company)) (VP (AUX is) (ADVP (RB still)) (VP (VBG looking) (PP (IN for) (`` `) (NP (NP (`` `) (DT a) (JJ strong) (JJ fourth) (NN quarter)) (PP (IN in) (NP (NP (DT all) (NNS areas)) (: --) (NP (NP (NNS sales)) (, ,) (NP (NN operating) (NN income)) (CC and) (NP (JJ net) (NN income)))))))))))) (. .)) )
(TOP (S ('' ') ('' ') (NP (NNP Mr.) (NNP Cawthorn)) (VP (VBD attributed) (NP (NP (DT the) (NN decline)) (PP (IN in) (NP (JJ third-quarter) (NN operating) (NN profit)))) (PP (PP (TO to) (NP (NP (DT the) (JJR stronger) (NN dollar)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ reduces) (NP (NP (DT the) (NN value)) (PP (IN of) (NP (JJ overseas) (NN profit)))) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (AUX is) (VP (VBN translated) (PP (IN into) (NP (NNS dollars))) (: ;) (PP (TO to) (NP (NP (VBN accelerated) (NN buying)) (PP (IN of) (NP (NNP Rorer) (NNS products))) (PP (IN in) (NP (DT the) (JJ second) (NN quarter))) (PP (IN because) (IN of) (NP (DT a) (JJ then-pending) (NNP July) (CD 1) (NN price) (NN increase)))))))))))))) (, ,) (CC and) (PP (TO to) (NP (NP (JJR higher) (NN marketing) (NNS expenses)) (PP (IN for) (NP (NP (NP (NNP Rorer) (POS 's)) (NNP Maalox) (NN antacid)) (, ,) (SBAR (WHNP (WHNP (WP$ whose) (NNS sales) (CC and) (NN market) (NN share)) (PP (IN in) (NP (DT the) (NNP U.S.)))) (S (VP (AUX had) (VP (VBN slipped) (PP (IN in) (NP (NP (DT the) (JJ first) (NN half)) (PP (IN of) (NP (date (CD 1989)))))))))))))))) (. .)) )
(TOP (S (NP (PRP He)) (VP (VBD said) (SBAR (S (NP (NNP Rorer)) (VP (VBD opted) (S (VP (TO to) (VP (VB sell) (NP (NNP Asilone) (CC and) (NNP Thrombinar)) (S (VP (TO to) (VP (VB raise) (NP (NP (NN revenue)) (SBAR (WHNP (WDT that)) (S (VP (MD would) (VP (`` `) (VP (`` `) (VB kick) (NP (NN start) (POS ')) ('' ') (NP (NP (PRP$ its) (VBN increased) (NN marketing) (NNS efforts)) (PP (IN behind) (NP (NP (NNP Maalox)) (, ,) (ADVP (RB still)) (NP (PRP$ its) (JJ top-selling) (NN product)) (PP (IN with) (NP (NP (QP (RB about) (money ($ $) (CD 215) (CD million)))) (PP (IN in) (NP (NP (JJ world-wide) (NNS sales)) (PP (IN in) (NP (date (CD 1988))))))))))))))))))))))))))) (. .)) )
(TOP (S (`` `) (S (`` `) (NP (PRP We)) (VP (AUX had) (VP (VBN underfunded) (NP (NNP Maalox)) (PP (IN for) (NP (DT a) (NN year)))))) (PRN (, ,) ('' ') ('' ') (S (NP (PRP he)) (VP (VBD said))) (, ,)) (SBAR (IN because) (S (NP (DT the) (NN company)) (VP (AUX was) (VP (VBG concentrating) (PP (IN on) (NP (NP (NN research) (CC and) (NN development)) (CC and) (S (VP (VBG promoting) (NP (JJ other) (NNS drugs)))))))))) (. .)) )
(TOP (S (NP (PRP He)) (VP (VBD said) (SBAR (S (NP (NNP Rorer)) (VP (MD will) (VP (VB spend) (NP (QP (money ($ $) (CD 15) (CD million) (TO to) ($ $) (CD 20) (CD million))) (JJR more)) (PP (IN on) (NP (NP (NNP Maalox) (NN advertising) (CC and) (NN promotion)) (PP (IN in) (NP (date (NP (DT the) (JJ second) (NN half)) (PP (IN of) (NP (CD 1989)))))))) (PP (IN than) (PP (IN in) (NP (DT the) (JJ year-earlier) (NN period))))))))) (. .)) )
(TOP (S (S (NP (DT A) (`` `) (NP (`` `) (JJ big) (NN chunk) ('' ')) ('' ') (PP (IN of) (NP (DT that) (JJ additional) (NN spending)))) (VP (VBD came) (PP (IN in) (NP (DT the) (date (JJ third) (NN quarter)))))) (, ,) (NP (PRP he)) (VP (VBD said)) (. .)) )
